Mark T. Boyd

Liverpool Head And Neck Cancer Centre
Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Urinary metabolite model to predict the dying process in lung cancer patients.

Urinary metabolite model to predict the dying process in lung cancer patients.

Journal: Communications medicine

Published: May 03, 2024

GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer.

GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer.

Journal: International journal of molecular sciences

Published: December 10, 2022

Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.

Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: October 10, 2022

Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines.

Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines.

Journal: Cancers

Published: September 06, 2021

Optimisation of Urine Sample Preparation for Headspace-Solid Phase Microextraction Gas Chromatography-Mass Spectrometry: Altering Sample pH, Sulphuric Acid Concentration and Phase Ratio.

Optimisation of Urine Sample Preparation for Headspace-Solid Phase Microextraction Gas Chromatography-Mass Spectrometry: Altering Sample pH, Sulphuric Acid Concentration and Phase Ratio.

Journal: Metabolites

Published: September 28, 2020

TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

Journal: Cancer letters

Published: July 24, 2019

Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.

Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.

Journal: The British journal of oral & maxillofacial surgery

Published: May 09, 2018

Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.

Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.

Journal: Oral oncology

Published: April 23, 2018

Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implications.

Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implications.

Journal: Lancet (London, England)

Published: August 28, 2015

Janus-faces of NME-oncoprotein interactions.

Janus-faces of NME-oncoprotein interactions.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 11, 2014

Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck.

Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck.

Journal: Head & neck

Published: May 29, 2014

Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.

Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.

Journal: Cancer letters

Published: April 11, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026